Analysts’ Viewpoint on Deep Brain Stimulation Devices Business for Parkinson’s Disease Scenario
Telehealth and eHealth apps are gaining popularity during the ongoing coronavirus pandemic to routinely monitor PD patients. Favorable reimbursement policies across healthcare facilities worldwide are contributing to the expansion of the deep brain stimulation devices market for Parkinson’s disease. However, there is a need for technological advancements in implantable pulse generators of DBS systems. Hence, companies in the global market for Parkinson’s disease should increase R&D for maximizing battery longevity, combined with patient-related elements such as reliability of IPG recharging or consistency of nightly device shutoff. Device-specific features such as parameter delivery, choice of lead configuration, implantation location, and careful selection of electrode materials to minimize impedance mismatch are crucial for med-tech companies to gain a competitive edge in the global market.
Companies operating in the deep brain stimulation devices market for Parkinson's disease are increasing efforts to commercialize devices in the global market. Products of other companies active in the market for DBS (deep brain stimulation) are not yet commercially available, as these are still under clinical trial. Companies are keen on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.
The containment measures taken by various government authorities during the ongoing coronavirus pandemic have caused the interruption of neurological activities in outpatient clinics. Vulnerable patients suffering from Parkinson's disease (PD) and dystonic patients with deep brain stimulation may have an increased risk of chronic stress related to social restriction measures and show a potential worsening of motor & psychiatric symptoms. In such cases, telehealth and eHealth mobile apps are playing a key role to address the symptoms of PD patients. Moreover, med-tech companies are increasing efforts to maintain a robust supply of DBS devices to prevent interruptions in the medical treatment of patients.
According to analysts at Transparency Market Research (TMR), the growing popularity of minimally invasive procedures is estimated to drive the demand for deep brain stimulation devices for Parkinson's disease. Deep brain stimulation surgical therapy is currently gaining traction and has risen to a popular therapy of choice when Parkinson's disease in the patient is at its advanced stage.
Since drug therapy is associated with certain adverse events, doctors, and patients are increasingly opting for deep brain stimulation surgical therapies. In addition, the efficacy of drug therapy cannot be determined in terms of certainty. This is another factor, which is driving doctors and patients to choose deep brain stimulation surgical therapy over drug therapy.
The global deep brain stimulation devices market for Parkinson’s disease is positioned to register a modest CAGR throughout the forecast period. North America is predicted to dictate the global market during the forecast period, accounting for more than 30% to 40% share by 2028. The market in the region is anticipated to reach significant value growth by 2028.
North America's largest market share can be attributed to an increase in the number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson’s disease and a surge in the geriatric population. Additionally, favorable government reimbursement policies and the risk of side effects related to medication treatments are expected to boost the growth of the deep brain stimulation devices market for Parkinson’s disease in the region.
The burgeoning growth of the geriatric population and the rise in demand for minimally invasive surgical techniques are triggering the growth of the deep brain stimulation devices market for Parkinson’s disease. Moreover, the change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the expansion of the global market in the upcoming decade. This is due to considerable side effects and loss of effectiveness of drugs & other therapeutics. This is anticipated to drive the market for DBS devices over the next few years.
The global market for DBS devices is predicted to register favorable Y-o-Y growth throughout the assessment period. However, there are a few factors, which are anticipated to go against the growth of the market. One of the key factors hampering the growth of this market is the associated risks involved with deep brain stimulation procedures.
For instance, an implantable pulse generator (IPG) is the core power supply and programmable element in DBS systems. However, the risk of infections due to IPG is expected to limit the use of deep brain stimulation devices for Parkinson's disease. Hence, healthcare stakeholders should increase awareness about antibiotic impregnation and co-administration & other surgical considerations during IPG implantation such as the use of tack-up sutures & smaller profile devices.
| Attribute | Detail |
|---|---|
| Market Size Value in 2020 (Base Year) | US$ 0.85 Bn |
| Market Forecast Value in 2028 | US$ 1.2 Bn |
| Growth Rate (CAGR) | 5.1% |
| Forecast Period | 2017-2028 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
| Format | Electronic (PDF) |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
Global market is expected to surpass the value of US$ 1.2 Bn by the end of 2028
The market for deep brain stimulation devices is estimated to expand at a CAGR of 5.1% from 2021 to 2028
The deep brain stimulation devices market is driven by an increase in the geriatric population and a rise in demand for minimally invasive surgical techniques
North America is projected to dominate the global market for deep brain stimulation devices during the forecast period
Key players operating in the global market include Medtronic, Inc., St. Jude Medical, Inc., and Boston Scientific Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, 2017-2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Product Type
6.1. Key Findings
6.2. Market Value Forecast, by Product Type
6.2.1. Single-Channel Deep Brain Stimulator
6.2.2. Dual-Channel Deep Brain Stimulator
6.3. Market Attractiveness Analysis, by Product Type
7. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by End-user
7.1. Key Findings
7.2. Market Value Forecast, by End-user
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Neurological Clinics
7.2.4. Others
7.3. Market Attractiveness Analysis, by End-user
8. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017-2028
9.2.1. Single-Channel Deep Brain Stimulator
9.2.2. Dual-Channel Deep Brain Stimulator
9.3. Market Attractiveness Analysis, by Product Type
9.4. Market Value Forecast, by End-user, 2017-2028
9.5. Market Value Forecast, by End-user
9.5.1. Hospitals
9.5.2. Ambulatory Surgical Centers
9.5.3. Neurological Clinics
9.5.4. Others
9.6. Market Attractiveness Analysis, by End-user
9.7. Market Value Forecast, by Country/Sub-region, 2017-2028
9.7.1. U.S.
9.7.2. Canada
9.8. Market Attractiveness Analysis
9.8.1. By Product Type
9.8.2. By End-user
9.8.3. By Country/Sub-region
10. Europe Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2028
10.2.1. Single-Channel Deep Brain Stimulator
10.2.2. Dual-Channel Deep Brain Stimulator
10.3. Market Attractiveness Analysis, by Product Type
10.4. Market Value Forecast, by End-user, 2017-2028
10.5. Market Value Forecast, by End-user
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Neurological Clinics
10.5.4. Others
10.6. Market Attractiveness Analysis, by End-user
10.7. Market Value Forecast, by Country/Sub-region, 2017-2028
10.7.1. Germany
10.7.2. U.K.
10.7.3. France
10.7.4. Spain
10.7.5. Italy
10.7.6. Rest of Europe
10.8. Market Attractiveness Analysis
10.8.1. By Product Type
10.8.2. By End-user
10.8.3. By Country/Sub-region
11. Asia Pacific Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2028
11.2.1. Single-Channel Deep Brain Stimulator
11.2.2. Dual-Channel Deep Brain Stimulator
11.3. Market Attractiveness Analysis, by Product Type
11.4. Market Value Forecast, by End-user, 2017-2028
11.5. Market Value Forecast, by End-user
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Neurological Clinics
11.5.4. Others
11.6. Market Attractiveness Analysis, by End-user
11.7. Market Value Forecast, by Country/Sub-region, 2017-2028
11.7.1. China
11.7.2. Japan
11.7.3. India
11.7.4. Australia & New Zealand
11.7.5. Rest of Asia Pacific
11.8. Market Attractiveness Analysis
11.8.1. By Product
11.8.2. By Application
11.8.3. By Country/Sub-region
12. Latin America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2028
12.2.1. Single-Channel Deep Brain Stimulator
12.2.2. Dual-Channel Deep Brain Stimulator
12.3. Market Attractiveness Analysis, by Product Type
12.4. Market Value Forecast, by End-user, 2017-2028
12.5. Market Value Forecast, by End-user
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Neurological Clinics
12.5.4. Others
12.6. Market Attractiveness Analysis, by End-user
12.7. Market Value Forecast, by Country/Sub-region, 2017-2028
12.7.1. Brazil
12.7.2. Mexico
12.7.3. Rest of Latin America
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Application
12.8.3. By Country/Sub-region
13. Middle East & Africa Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2028
13.2.1. Single-Channel Deep Brain Stimulator
13.2.2. Dual-Channel Deep Brain Stimulator
13.3. Market Attractiveness Analysis, by Product Type
13.4. Market Value Forecast, by End-user, 2017-2028
13.5. Market Value Forecast, by End-user
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Neurological Clinics
13.5.4. Others
13.6. Market Attractiveness Analysis, by End-user
13.7. Market Value Forecast, by Country/Sub-region, 2017-2028
13.7.1. GCC Countries
13.7.2. South Africa
13.7.3. Rest of Middle East & Africa
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Application
13.8.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Aleva Neurotherapeutics SA
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Boston Scientific Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Medtronic, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Medtronic
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
List of Tables
TABLE 1: Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
TABLE 2: Relationship Between Age and the Occurrence of Parkinson’s Disease
TABLE 3: Deep Brain Stimulation Device’s U.S. FDA approval for Various Neurological Disorders
TABLE 4: Global Prevalence of Parkinson’s Disease, by Geography, 2017-2028 (Number of Patients)
TABLE 5: Global Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Geography, 2017-2028
TABLE 6: Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Region, 2017-2028
TABLE 7: North America Prevalence of Parkinson’s Disease, by Country, 2017-2028 (Number of Patients)
TABLE 8: North America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017-2028
TABLE 9: North America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017-2028
TABLE 10: Europe Prevalence of Parkinson’s Disease, by Country, 2017-2028 (Number of Patients)
TABLE 11: Europe Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017-2028
TABLE 12: Europe Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017-2028
TABLE 13: Asia Pacific Prevalence of Parkinson’s Disease, by Country, 2017-2028 (Number of Patients)
TABLE 14: Asia Pacific Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017-2028
TABLE 15: Asia Pacific Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017-2028
TABLE 16: Latin America Prevalence of Parkinson’s Disease, by Country, 2017-2028 (Number of Patients)
TABLE 17: Latin America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017-2028
TABLE 18: Latin America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017-2028
TABLE 19: Middle East & Africa Prevalence of Parkinson’s Disease, by Country, 2017-2028 (Number of Patients)
TABLE 20: Middle East & Africa Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017-2028
TABLE 21: Middle East & Africa Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017-2028
List of Figures
Figure 1: Deep Brain Stimulation Devices for Parkinson’s Disease: Market Segmentation
Figure 2: Global DBS Devices Market for Parkinson’s Disease (US$ Mn), by Region, 2020
Figure 3: Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease (Value %), by Geography, 2020 & 2028
Figure 4: Porter’s Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
Figure 5: Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
Figure 6: Market Share by Key Players: Global Deep Brain Stimulation Devices Market for Parkinson’s disease, 2020 (Value %) , by Geography, 2020
Figure 7: United States Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017-2028
Figure 8: Canada Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017-2028
Figure 9: Germany Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017-2028
Figure 10: Italy Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 11: Spain Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 12: United Kingdom Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 13: France Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 14: RoE Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 15: Australia Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 16: China Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 17: India Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 18: New Zealand Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 19: Japan Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 20: Rest of APAC Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 21: Brazil Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 22: Mexico Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 23: Latin America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Figure 24: Middle East & Africa Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017-2028
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Deep Brain Stimulation Devices Market
